8-Bromoguanosine-3′,5′-cyclomonophosphate sodium salt

• Catalog No.: 17110
• CAS Number: 51116-01-9
• M. F.: C10H10BrN5NaO7P
• M. W.: 446.083231
• Purity: ≥99.0% (HPLC)

SYNONYMS

• IUPAC name: sodium (4aR,6R,7R,7aS)-6-(2-amino-8-bromo-6-oxo-6,9-dihydro-1H-purin-9-yl)-7-hydroxy-2-oxo-hexahydro-1,3,5,2λ^5-furo[3,2-d][1,3,2λ^5]dioxaphosphinin-2-olate
• IUPAC Traditional name: sodium (4aR,6R,7R,7aS)-6-(2-amino-8-bromo-6-oxo-1H-purin-9-yl)-7-hydroxy-2-oxo-tetrahydro-4H-1,3,5,2λ^5-furo[3,2-d][1,3,2λ^5]dioxaphosphinin-2-olate
• Synonyms: 8-Br-cGMP

DATABASE IDS

• Beilstein Number: 8378760
• CAS Number: 51116-01-9
• MDL Number: MFCD00070128
• EC Number: 256-993-8

PROPERTIES

• Empirical Formula (Hill Notation): C10H10BrN5NaO7P
• Impurities: ≤1% guanosine 3′,5′-cyclophosphate (HPLC)
• Impurities: ≤8% water(2 mol/mol)
• Purity: ≥99.0% (HPLC)
• Solubility: H2O: soluble0.1 g/mL, clear, slightly yellow
• Personal Protective Equipment: Eyeshields, Gloves, type N95 (US), type P1 (EN143) respirator filter
• Storage Temperature: -20°C
• German water hazard class: 3

DETAILS

Description (English)

Other Notes
A membrane-permeable cGMP derivative. Induces HL-60 cells to differentiate along the granulocytic pathway1

Description (简体中文)

Other Notes
A membrane-permeable cGMP derivative. Induces HL-60 cells to differentiate along the granulocytic pathway1